Cargando…
Pharmacological Preconditioning with GYKI 52466: A Prophylactic Approach to Neuroprotection
Some toxins and drugs can trigger lasting neuroprotective mechanisms that enable neurons to resist a subsequent severe insult. This “pharmacological preconditioning” has far-reaching implications for conditions in which blood flow to the brain is interrupted. We have previously shown that in vitro p...
Autores principales: | Goulton, Chelsea S., Patten, Anna R., Kerr, John R., Kerr, D. Steven |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955399/ https://www.ncbi.nlm.nih.gov/pubmed/20953290 http://dx.doi.org/10.3389/fnins.2010.00054 |
Ejemplares similares
-
Mechanism of Inhibition of the GluA1 AMPA Receptor
Channel Opening by the 2,3-Benzodiazepine Compound GYKI 52466 and
a N-Methyl-Carbamoyl Derivative
por: Wu, Andrew, et al.
Publicado: (2014) -
Mitochondrial Preconditioning: A Potential Neuroprotective Strategy
por: Correia, Sónia C., et al.
Publicado: (2010) -
Strategies for Study of Neuroprotection from Cold-preconditioning
por: Mitchell, Heidi M., et al.
Publicado: (2010) -
Novel Cellular Mechanisms for Neuroprotection in Ischemic Preconditioning: A View from Inside Organelles
por: Sisalli, Maria Josè, et al.
Publicado: (2015) -
Small-angle neutron scattering studies on the AMPA receptor GluA2 in the resting, AMPA-bound and GYKI-53655-bound states
por: Larsen, Andreas Haahr, et al.
Publicado: (2018)